News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BLAIR JAMES C
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| BLAIR JAMES C (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 40,138 options to buy
@ $6.48, valued at
$260.1k
|
|
| 08/20/2019 |
4
| BLAIR JAMES C (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Bought 20,000 shares
@ $5.7, valued at
$114k
Bought 20,000 shares
@ $5.97, valued at
$119.4k
|
|
| 08/08/2019 |
4
| DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Bought 250,000 shares
@ $4, valued at
$1M
Bought 187,500 options to buy
@ $4.4, valued at
$825k
|
|
| 06/10/2019 |
4
| BLAIR JAMES C (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 28,882 options to buy
@ $14.66, valued at
$423.4k
|
|
| 05/13/2019 |
3
| DP VIII Associates, L.P. (10% Owner) has filed a Form 3 on Alliqua BioMedical, Inc. |
| 05/13/2019 |
3
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 3 on Alliqua BioMedical, Inc. |
| 05/10/2019 |
4
| BLAIR JAMES C (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 20,000 options to buy
@ $0.5834, valued at
$11.7k
|
|
| 03/18/2019 |
4
| BLAIR JAMES C (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 17,056 shares
@ $27.79, valued at
$474k
Disposed of 10,000 shares
@ $0
Acquired 701 shares
@ $0
Acquired 522 shares
@ $0 |
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2018 |
4
| DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Bought 1,648,359 shares
@ $1.82, valued at
$3M
|
|
| 08/27/2018 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on BioNano Genomics, Inc|
Txns:
| Converted 4,386 shares
@ $0
Converted 2,505 shares
@ $4.59, valued at
$11.5k
Converted 50,532 preferred shares
@ $0
Converted 22,161 preferred shares
@ $0
Converted 40,268 preferred shares
@ $0
Converted 47,460 preferred shares
@ $0
Converted 27,328 preferred shares
@ $0
Converted convertible notes
@ $0 |
|
| 08/27/2018 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on BioNano Genomics, Inc|
Txns:
| Converted 591,184 shares
@ $0
Converted 337,694 shares
@ $4.59, valued at
$1.6M
Bought 15,000 shares
@ $6.125, valued at
$91.9k
Converted 6,810,098 preferred shares
@ $0
Converted 2,986,762 preferred shares
@ $0
Converted 5,426,808 preferred shares
@ $0
Converted 6,396,105 preferred shares
@ $0
Converted 3,682,919 preferred shares
@ $0
Converted convertible notes
@ $0
Bought 15,000 options to buy
@ $6.125, valued at
$91.9k
|
|
| 08/21/2018 |
3
| DP VIII Associates, L.P. (10% Owner) has filed a Form 3 on BioNano Genomics, Inc |
| 08/21/2018 |
3
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 3 on BioNano Genomics, Inc |
| 08/21/2018 |
3
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 3 on BioNano Genomics, Inc |
| 05/23/2018 |
4
| BLAIR JAMES C (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Acquired 5,897 shares
@ $0
Disposed of 32,760 shares
@ $0 |
|
| 05/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2017 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Converted 12,444 shares
@ $3.19, valued at
$39.7k
Granted 282 shares
@ $0
Converted 368 options to buy
@ $3.19, valued at
$1.2k
|
|
| 12/20/2017 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Converted 1,678,432 shares
@ $3.19, valued at
$5.4M
Granted 37,890 shares
@ $0
Converted 49,632 options to buy
@ $3.19, valued at
$158.3k
|
|
| 12/13/2017 |
4
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 47,963 shares
@ $0 |
|
| 12/13/2017 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 15,731 shares
@ $0 |
|
| 12/13/2017 |
4
| Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 1,857,036 shares
@ $0
Disposed/sold 20,150 options to buy
@ $0.67, valued at
$13.5k
|
|
| 12/13/2017 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 7,333 shares
@ $0 |
|
| 12/13/2017 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 988,285 shares
@ $0 |
|
| 08/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2017 |
4
| BLAIR JAMES C (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Sold 18,450 shares
@ $78.61, valued at
$1.5M
|
|
| 06/27/2017 |
4
| BLAIR JAMES C (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Disposed of 286,857 shares
@ $0
Acquired 2,869 shares
@ $0 |
|
| 06/12/2017 |
4
| BLAIR JAMES C (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 10,000 options to buy
@ $59.56, valued at
$595.6k
|
|
| 05/23/2017 |
4/A
| BLAIR JAMES C (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Disposed of 41,813 shares
@ $0
Acquired 2,185 shares
@ $0
Acquired 2,927 shares
@ $0 |
|
| 05/11/2017 |
4
| BLAIR JAMES C (Director) has filed a Form 4 on aTYR PHARMA INC |
| 04/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|